November 12, 2014
Notes: Nagayama, Daiji
Nihon Rinsho. 2013 Sep;71(9):1602-5.
Author Address: Center of Diabetes, Endocrinology and Metabolism.
Reference Type: Journal Article
Record Number: 4728Author: Nakamura, T., Ito, T., Uchida, M., Hijioka, M., Igarashi, H., Oono, T., Kato, M., Nakamura, K., Suzuki, K., Jensen, R. T. and Takayanagi, R.
Title: PSCs and GLP-1R: occurrence in normal pancreas, acute/chronic pancreatitis and effect of their activation by a GLP-1R agonist
Journal: Lab Invest
Short Title: PSCs and GLP-1R: occurrence in normal pancreas, acute/chronic pancreatitis and effect of their activation by a GLP-1R agonist
Alternate Journal: Laboratory investigation; a journal of technical methods and pathology
ISSN: 1530-0307 (Electronic)
Accession Number: 24217090
Cell Proliferation/drug effects
Extracellular Signal-Regulated MAP Kinases/metabolism
Glucagon-Like Peptide 1/analogs & derivatives/pharmacology
Pancreatic Stellate Cells/drug effects/*metabolism
Pancreatitis, Acute Necrotizing/*metabolism
Signal Transduction/drug effects
Abstract: There is increasing concern about the development of pancreatitis in patients with diabetes mellitus who received long-term glucagon-like peptide-1 (GLP-1) analog treatment. Its pathogenesis is unknown. The effects of GLP-1 agonists on pancreatic endocrine cells are well studied; however, there is little information on effects on other pancreatic tissues that might be involved in inflammatory processes. Pancreatic stellate cells (PSCs) can have an important role in pancreatitis, secreting various inflammatory cytokines/chemokines, as well as collagen. In this study, we investigated GLP-1R occurrence in normal pancreas, acute pancreatitis (AP)/chronic pancreatitis (CP), and the effects of GLP-1 analog on normal PSCs, their ability to stimulate inflammatory mediator secretion or proliferation. GLP-1 receptor (GLP-1R) expression/localization in normal pancreas and pancreatitis (AP/CP) tissues were evaluated with histological/immunohistochemical analysis. PSCs were isolated from male Wistar rats. GLP-1R expression and effects of GLP-1 analog on activated PSCs was examined with real-time PCR, MTS assays and western blotting. In normal pancreas, pancreatic beta cells expressed GLP-1R, with only low expression in acinar cells, whereas in AP or CP, acinar cells, ductal cells and activated PSCs expressed GLP-1R. With activation of normal PSCs, GLP-1R is markedly increased, as is multiple other incretin-related receptors. The GLP-1 analog, liraglutide, did not induce inflammatory genes expression in activated PSCs, but induced proliferation. Liraglutide activated multiple signaling cascades in PSCs, and the extracellular signal-regulated kinase pathway mediated the PSCs proliferation. GLP-1Rs are expressed in normal pancreas and there is marked enhanced expression in AP/CP. GLP-1-agonist induced cell proliferation of activated PSCs without increasing release of inflammatory mediators. These results suggest chronic treatment with GLP-1R agonists could lead to proliferation/chronic activation of PSCs, which may lead to important effects in the pancreas.